Following the remarkable results on BACH2 and PRDM1 that could be associated with age-related immune deterioration in HDs, we analyzed BACH2 and PRDM1 gene expression in untreated CLL patients who were not on any medication that might influence their immune response. The gene discussed is BACH2; the disease is B-cell chronic lymphocytic leukemia.